This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use.

Need any help? Call us on
01270 258530

ECHA announces a number of substances that have been shortlisted for possible regulatory action

25 January 2017

During their annual IT screening exercise, ECHA has selected 162substances for further scrutiny by Member State competent authorities. The competent authorities will carry out a manual examination of the dossiers they prioritise to determine whether regulatory action is necessary.

The selection is based on an automated IT system and focuses on substances with potential carcinogenic, mutagenic or toxic to reproduction (CMR), persistent, bioaccumulative and toxic (PBT), endocrine disrupting, sensitising or specific target organ toxicity following repeat exposure (STOT RE) properties. These substances with these potential hazardous properties are then further prioritised based on uses that are likely to lead to exposure to humans or release to the environment.

If your company has registered one of the substances that have been shortlisted, you will receive a letter from ECHA informing of the potential examination of the registration(s). Companies should ensure they are monitoring their REACH-IT inbox for this and any other potential correspondence from ECHA. Both ECHA and ReFaC encourage you to update your dossiers to address any shortcomings as soon as possible. This is because up to date information will assist the Member State authorities to better access whether the concern indicated by the screening is validated, and whether regulatory action is still required.

If actions are to be taken on the substance you have registered, this will be published on the ECHA website. You will be able to check the status of your substance(s) through the Search for chemicals function on ECHA’s website.

ECHA are hosting a webinar on the 14th February that will give more details on the screening process. This webinar will also provide you the opportunity to ask questions of ECHA staff.

If you would like to discuss updating your dossier with ReFaC, contact us now.

Cookies required

To use this functionality please enable cookies. Find out more about our cookie policy.

  Cookies are currently off.